Dcm Advisors, LLC Danaher Corp Transaction History

Dcm Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$185.1 - $233.13 $462,750 - $582,825	2,500 New	2,500 $578,000
Q4 2022 Sep 08, 2023	SELL	$241.42 - $282.29 $839,417 - $981,522	-3,477 Closed	0 $0
Q3 2022 Sep 08, 2023	SELL	$247.06 - $1507.4 $79,553 - $485,382	-322 Reduced 8.48%	3,477 $898,000
Q2 2022 Aug 15, 2022	BUY	$237.11 - $299.66 $132,070 - $166,910	557 Added 17.18%	3,799 $963,000
Q1 2022 May 09, 2022	SELL	$257.27 - $315.76 $94,932 - $116,515	-369 Reduced 10.22%	3,242 $951,000
Q4 2021 Feb 11, 2022	BUY	$292.08 - $329.01 $290,911 - $327,693	996 Added 38.09%	3,611 $1.19 Million
Q3 2021 Nov 15, 2021	BUY	$272.21 - $332.43 $711,829 - $869,304	2,615 New	2,615 $796,000
Q1 2021 May 17, 2021	SELL	$212.38 - $245.9 $1.13 Million - $1.3 Million	-5,302 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$212.5 - $245.46 $1.13 Million - $1.3 Million	5,302 New	5,302 $1.18 Million

2,507

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $170B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Dcm Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Dcm Advisors, LLC with notifications on news.